Digital Microfluidic Platform for Multiplexing Enzyme Assays: Implications for Lysosomal Storage Disease Screening in Newborns
Ramakrishna S. Sista, Allen E. Eckhardt, Tong Wang et al. · Clinical Chemistry · 2011
BACKGROUND: Newborn screening for lysosomal storage diseases (LSDs) has been gaining considerable interest owing to the availability of enzyme replacement therapies. We present a digital microfluidic platform to perform rapid, multiplexed enzymatic analysis of acid α-glucosidase (GAA) and acid α-galactosidase to screen for Pompe and Fabry disorders. The results were compared with those obtained using standard fluorometric methods. METHODS: We performed bench-based, fluorometric enzymatic analysis on 60 deidentified newborn dried blood spots (DBSs), plus 10 Pompe-affected and 11 Fabry-affected samples, at Duke Biochemical Genetics Laboratory using a 3-mm punch for each assay and an incubation time of 20 h. We used a digital microfluidic platform to automate fluorometric enzymatic assays at Advanced Liquid Logic Inc. using extract from a single punch for both assays, with an incubation time of 6 h. Assays were also performed with an incubation time of 1 h. RESULTS: Assay results were generally comparable, although mean enzymatic activity for GAA using microfluidics was approximately 3 times higher than that obtained using bench-based methods, which could be attributed to higher substrate concentration. Clear separation was observed between the normal and affected samples at both 6- and 1-h incubation times using digital microfluidics. CONCLUSIONS: A digital microfluidic platform compared favorably with a clinical reference laboratory to perform enzymatic analysis in DBSs for Pompe and Fabry disorders. This platform presents a new technology for a newborn screening laboratory to screen LSDs by fully automating all the liquid-handling operations in an inexpensive system, providing rapid results.
Cited by 111 works. doi:10.1373/clinchem.2011.163139 Open-access PDF
Authors
- Ramakrishna S. Sista
- Allen E. Eckhardt
- Carrie Graham
- Jeremy L. Rouse
- Scott M. Norton
- Vijay Srinivasan
- Michael G. Pollack
- Adviye Ayper Tolun
- Deeksha Sarihyan Bali
- David S. Millington
- Vamsee K. Pamula
References
- The Metabolic and Molecular Bases of Inherited Disease
- The metabolic and molecular bases of inherited disease
- A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS
- α-Galactosidase A deficiency. Fabry disease
- An integrated digital microfluidic lab-on-a-chip for clinical diagnostics on human physiological fluidsThe Science and Application of Droplets in Microfluidic Devices.Electronic supplementary information (ESI) available: five video clips showing: high-speed transport of a droplet of blood across 4 electrodes; sample injection into an on-chip reservoir using an external pipette; droplet formation from an on-chip reservoir using only electrowetting forces; droplets moving in-phase on a 3-phase transport bus; and a pipelined glucose assay, showing sample and reagent droplet formation, mixing, splitting and colorimetric reaction. See http://www.rsc.org/suppdata/lc/b4/b403341h/
- Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism
- Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn Screening
- Development of a digital microfluidic platform for point of care testing
- Fabry disease: enzymatic diagnosis in dried blood spots on filter paper
- Recoveries of Phenylalanine from Two Sets of Dried-Blood-Spot Reference Materials: Prediction from Hematocrit, Spot Volume, and Paper Matrix